Specific IgE antibodies in twenty-eight workers with diisocyanate-induced bronchial asthma. 1984

A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente

A specific IgE-mediated response was evaluated in twenty-eight workers exposed to TDI or MDI, with diagnosis of occupational asthma and positive to bronchial provocative challenge. The presence of anti-diisocyanate IgE was observed in 27% of subjects exposed to TDI and 83% of those exposed to MDI, particularly in individuals who experienced an acute massive exposure. An immediate-type response to bronchial provocative test was found in 66% of individuals with specific antibodies. Specific IgE are prevalent (91%) in subjects who developed symptoms before 6 years of exposure to isocyanates. The results suggest an association between the presence of specific IgE, early asthmatic symptoms and heavy episodic exposure.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008297 Male Males
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D003485 Cyanates Organic salts of cyanic acid containing the -OCN radical. Cyanate
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D014051 Toluene 2,4-Diisocyanate Skin irritant and allergen used in the manufacture of polyurethane foams and other elastomers. Diisocyanatotoluene,Tolylene Diisocyanate,2,4-Toluenediisocyanate,Toluene Diisocyanate,2,4 Toluenediisocyanate,2,4-Diisocyanate, Toluene,Diisocyanate, Toluene,Diisocyanate, Tolylene,Toluene 2,4 Diisocyanate

Related Publications

A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
June 1986, Annals of allergy,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
January 1988, Vutreshni bolesti,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
January 2013, Iranian journal of public health,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
January 1979, La Medicina del lavoro,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
December 1925, Canadian Medical Association journal,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
June 1978, American Industrial Hygiene Association journal,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
May 1982, Clinical allergy,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
December 1980, Allergy,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
January 1980, Clinical allergy,
A Pezzini, and A Riviera, and P Paggiaro, and A Spiazzi, and F Gerosa, and M Filieri, and G Toma, and G Tridente
January 1979, Journal of environmental science and health. Part C: Environmental health sciences,
Copied contents to your clipboard!